Schoenberger Scott D, Miller Daniel M, Riemann Christopher D, Foster Robert E, Sisk Robert A, Hutchins Robert K, Petersen Michael R
Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, OH 45242, USA.
Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec;42(6):474-80. doi: 10.3928/15428877-20110901-02. Epub 2011 Sep 8.
To report outcomes and complications of 25-gauge pars plana vitrectomy (PPV) for patients with complications of proliferative diabetic retinopathy (PDR).
Retrospective, interventional, consecutive case series of 174 eyes undergoing primary 25-gauge PPV for PDR from 2006 to 2009. Primary outcomes were visual acuity changes and rates of postoperative complications.
Visual acuity improved from 20/187 before to 20/69 after surgery (P < .0001). Postoperative vitreous hemorrhage occurred in 38.7% of eyes and 10.4% of all eyes required another PPV for non-clearing vitreous hemorrhage. Complications included limited choroidal effusion (5.2%), rhegmatogenous retinal detachment (4.6%), hypotony, rubeosis, and ocular hypertension (4.1%), neovascular glaucoma (2.3%), hyphema (1.2%), and phthisis bulbi (0.6%).
The authors found 25-gauge PPV to be effective for vitreous removal and membrane dissection. The spectrum and frequency of complications were similar to those reported for 20-gauge PPV for PDR. In the surgical management of PDR, 25-gauge PPV is an alternative.
报告25G玻璃体切割术治疗增殖性糖尿病视网膜病变(PDR)并发症患者的疗效及并发症情况。
回顾性、干预性、连续病例系列研究,纳入2006年至2009年接受初次25G玻璃体切割术治疗PDR的174只眼。主要观察指标为视力变化及术后并发症发生率。
视力从术前的20/187提高至术后的20/69(P <.0001)。38.7%的患眼发生术后玻璃体出血,10.4%的患眼因玻璃体出血不吸收需再次行玻璃体切割术。并发症包括局限性脉络膜脱离(5.2%)、孔源性视网膜脱离(4.6%)、低眼压、虹膜红变及高眼压(4.1%)、新生血管性青光眼(2.3%)、前房积血(1.2%)和眼球痨(0.6%)。
作者发现25G玻璃体切割术在玻璃体切除及膜剥除方面有效。并发症的范围和发生率与报道的20G玻璃体切割术治疗PDR的情况相似。在PDR的手术治疗中,25G玻璃体切割术是一种选择。